Literature DB >> 28831645

Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.

Kyoko Kikuchi1, Keely May McNamara2, Yasuhiro Miki3, Ju-Yeon Moon4, Man Ho Choi4, Fumiya Omata1, Minako Sakurai1, Yoshiaki Onodera1, Yoshiaki Rai5, Yasuyo Ohi5, Yasuaki Sagara5, Minoru Miyashita6, Takanori Ishida6, Noriaki Ohuchi6, Hironobu Sasano1.   

Abstract

PURPOSE: The tumor microenvironment plays pivotal roles in promotion of many malignancies. Cancer-associated fibroblasts (CAFs) have been well-known to promote proliferation, angiogenesis, and metastasis but mechanistic understanding of tumor-stroma interactions is not yet complete. Recently, estrogen synthetic enzymes were reported to be upregulated by co-culture with stromal cells in ER positive breast carcinoma (BC) but effects of co-culture on androgen metabolism have not been extensively examined. Therefore, we evaluated roles of CAFs on androgen metabolism in ER-negative AR-positive BC through co-culture with CAFs.
METHODS: Concentrations of steroid hormone in supernatant of co-culture of MDA-MB-453 and primary CAFs were measured using GC-MS. Cytokines derived from CAFs were determined using Cytokine Array. Expressions of androgen synthetic enzymes were confirmed using RT-PCR and Western blotting. Correlations between CAFs and androgen synthetic enzymes were analyzed using triple-negative BC (TNBC) patient tissues by immunohistochemistry.
RESULTS: CAFs were demonstrated to increase expressions and activities of 17βHSD2, 17βHSD5, and 5α-Reductase1. IL-6 and HGF that were selected as potential paracrine mediators using cytokine array induced 17βHSD2, 17βHSD5, and 5α-Reductase1 expression. Underlying mechanisms of IL-6 paracrine regulation of 17βHSD2 and 17βHSD5 could be partially dependent on phosphorylated STAT3, while phosphorylated ERK could be involved in HGF-mediated 5α-Reductase1 induction. α-SMA status was also demonstrated to be significantly correlated with 17βHSD2 and 17βHSD5 status in TNBC tissues, especially AR-positive cases.
CONCLUSIONS: Results of our present study suggest that both IL-6 and HGF derived from CAFs could contribute to the intratumoral androgen metabolism in ER-negative BC patients.

Entities:  

Keywords:  Androgen; Breast cancer; Cancer-associated fibroblasts (CAFs); Microenvironment; Triple-negative breast cancer (TNBC)

Mesh:

Substances:

Year:  2017        PMID: 28831645     DOI: 10.1007/s10549-017-4464-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging.

Authors:  Tao Zhang; Ping Zhang; Hong-Xia Li
Journal:  Int J Nanomedicine       Date:  2021-01-25

2.  ERα36-High Cancer-Associated Fibroblasts as an Unfavorable Factor in Triple-Negative Breast Cancer.

Authors:  Anna Nagel; Marta Popeda; Anna Muchlinska; Rafal Sadej; Jolanta Szade; Jacek Zielinski; Jaroslaw Skokowski; Magdalena Niemira; Adam Kretowski; Aleksandra Markiewicz; Anna J Zaczek
Journal:  Cancers (Basel)       Date:  2022-04-15       Impact factor: 6.575

3.  Ceritinib is a novel triple negative breast cancer therapeutic agent.

Authors:  Shengli Dong; Hassan Yousefi; Isabella Van Savage; Samuel C Okpechi; Maryl K Wright; Margarite D Matossian; Bridgette M Collins-Burow; Matthew E Burow; Suresh K Alahari
Journal:  Mol Cancer       Date:  2022-06-29       Impact factor: 41.444

4.  Inhibition of Tumor Microenvironment Cytokine Signaling Sensitizes Ovarian Cancer Cells to Antiestrogen Therapy.

Authors:  Lijun Tan; Katelyn Tondo-Steele; Caroline Foster; Carrie McIlwain; Danielle E Bolland; Howard C Crawford; Andrew Sciallis; Karen McLean
Journal:  Cancers (Basel)       Date:  2022-09-26       Impact factor: 6.575

Review 5.  Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.

Authors:  Jarupa Soongsathitanon; Pranisa Jamjuntra; Nuttavut Sumransub; Supaporn Yangngam; Marjorie De la Fuente; Glauben Landskron; Peti Thuwajit; Marcela A Hermoso; Chanitra Thuwajit
Journal:  J Immunol Res       Date:  2021-07-13       Impact factor: 4.818

6.  Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway.

Authors:  Quanhui Zhang; Junping Yang; Jie Bai; Jianzhuang Ren
Journal:  Cancer Sci       Date:  2018-03-25       Impact factor: 6.716

7.  Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway.

Authors:  Jun Ma; Xiao Song; Xiaowu Xu; Yiping Mou
Journal:  Cancer Res Treat       Date:  2018-04-20       Impact factor: 4.679

8.  New Insights into Breast and Endometrial Cancers.

Authors:  Yasuhiro Miki
Journal:  Cancers (Basel)       Date:  2020-09-11       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.